Of note, HER2 fluorescence in situ hybridization assessment was not performed on any of the 74 included CRC patients in this study, although there is data indicating that between 2.5–26.7% of CRC harbour HER2 positivity [65,66]. Here, ERBB2 is linked to colorectal carcinoma.